RecruitingNCT05619900

Registry of Patients Diagnosed With Lysosomal Storage Diseases


Sponsor

University of California, San Francisco

Enrollment

250 participants

Start Date

May 31, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This is an international prospective and retrospective registry of patients with Lysosomal Storage Diseases (LSDs) to understand the natural history of the disease and the outcomes of fetal therapies, with the overall goal of improving the prenatal management of patients with LSDs.


Eligibility

Max Age: 64 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying There is no intervention for people with mucopolysaccharidosis i, mucopolysaccharidosis ii, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 64 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERThere is no intervention

This is an observational study. There is no intervention. The purpose of the project is to create a database of patients diagnosed either prenatally or after birth with a lysosomal storage disease. The database will be utilized to assess patient outcomes, build on existing clinical management, improve medical decision making, and improve quality of care.


Locations(1)

University of California San Francisco

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05619900


Related Trials